Denosumab and Male Infertility: a RCT

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
To determine the significance of systemic RANKL inhibition for male reproduction, conducting a clinical controlled randomized double blinded intervention study on infertile men, to investigating whether Denosumab (Prolia) can increase semen quality and to investigate what subgroup of infertile men that might benefit from treatment.
Epistemonikos ID: 982aa50068358698b1759c0635d065496839a8a5
First added on: May 20, 2024